pegvaliase

Trials studying pegvaliase

• phase3Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuriaactive not recruitingn=55
• phase4Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziqactive not recruitingn=9
• —A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)recruitingn=450
• —A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)recruitingn=200
• —A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeedingrecruitingn=50
• phase4Immune Modulation During Palynziq® Treatment in Adults (IMPALA)not yet recruitingn=12
• —Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)recruitingn=45
• —Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKUcompletedn=6